Atlas Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$426K Buy
1,444
+1
+0.1% +$297 0.44% 35
2025
Q4
$394K Buy
1,443
+125
+9% +$34K 0.43% 36
2025
Q3
$356K Buy
1,318
+1
+0.1% +$272 0.36% 36
2025
Q2
$363K Sell
1,317
-50
-4% -$13.6K 0.42% 34
2025
Q1
$363K Buy
1,367
+1
+0.1% +$247 0.45% 29
2024
Q4
$333K Hold
1,366
0.42% 30
2024
Q3
$301K Buy
1,366
+80
+6% +$16.6K 0.46% 35
2024
Q2
$253K Buy
1,286
+7
+0.5% +$1.45K 1.07% 19
2024
Q1
$266K Buy
1,279
+55
+4% +$11.6K 1.44% 14
2023
Q4
$253K Buy
+1,224
New +$261K 1.4% 16

Other funds holding CME

Atlas Wealth Partners's CME Position: Q1 2026 in Review

Atlas Wealth Partners increased its CME Group (CME) stake by 0.07% in Q1 2026, buying an estimated $297 and bringing the position to 1,444 shares worth $426K. The position accounts for 0.44% of the portfolio, ranked #35.

Atlas Wealth Partners first reported a position in CME in Q4 2023 and has held it in 10 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Atlas Wealth Partners held 1,444 shares of CME Group worth $426K as of Q1 2026.
  • Atlas Wealth Partners bought 1 CME Group share in Q1 2026, an estimated $297.
  • CME Group made up 0.44% of Atlas Wealth Partners's portfolio in Q1 2026, its #35 holding.
  • Atlas Wealth Partners first reported a position in CME Group in Q4 2023 and has held it in 10 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Atlas Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.